NanoSphere Health Sciences Inc.

NSHS

CA63010P2098

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:29:27 2024-05-02 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	+150.00%

Apr. 30	NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Nanosphere Health Sciences Inc. Announces Earnings Results for the First Quarter Ended March 31, 2020

July 15, 2020 at 04:39 pm EDT

NanoSphere Health Sciences Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced net loss was USD 235,284 compared to USD 728,958 a year ago.

Latest news about NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	23-04-27	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	22-04-24	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
NanoSphere Health Sciences Inc. announced that it expects to receive CAD 0.234 million in funding	21-09-16	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-31	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	21-04-29	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-29	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-28	CI
Nanosphere Health Sciences Inc. Announces Earnings Results for the First Quarter Ended March 31, 2020	20-07-15	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-15	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	20-06-14	CI
NanoSphere Health Sciences Inc. Announces Resignation of Mark Percival as CEO	20-04-21	CI
NanoSphere Health Sciences Inc. Provides Update on United States Operations	19-12-09	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-28	CI

Chart NanoSphere Health Sciences Inc.

Duration

Period

More charts

Company Profile

NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Companyâs operating division in the United States.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
NANOSPHERE HEALTH SCIENCES INC.	+150.00%	187K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.98%	43.67B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.51B
SANDOZ GROUP AG	+14.78%	14.6B
CIPLA LIMITED	+14.32%	13.74B
ZYDUS LIFESCIENCES LIMITED	+44.72%	11.91B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	7.04B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.42B